These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [The need for integrated care of patients with chronic nephropathies: the epidemiology of 'late referral']. Casino FG; Vitullo F; Sorrentino GC; Di Matteo A; Procida M; Gaudiano V; Venezia A; Sinisi R; Di Candia VD G Ital Nefrol; 2002; 19(2):143-8. PubMed ID: 12195412 [TBL] [Abstract][Full Text] [Related]
44. Nephrology referral and appropriateness of therapeutic drug care in chronic kidney disease. Thilly N; Boini S; Kessler M; Briançon S; Frimat L J Nephrol; 2006; 19(3):303-11. PubMed ID: 16874689 [TBL] [Abstract][Full Text] [Related]
45. Medication adherence in patients with chronic kidney disease. Raymond CB; Wazny LD; Sood AR CANNT J; 2011; 21(2):47-50; quiz 51-2. PubMed ID: 21894841 [No Abstract] [Full Text] [Related]
46. It's about time: extending our understanding of cardiovascular risk from chronic kidney disease. Young A; Garg AX J Am Soc Nephrol; 2009 Dec; 20(12):2486-7. PubMed ID: 19892933 [No Abstract] [Full Text] [Related]
47. [Hypertension and kidney]. Abe T Nihon Jinzo Gakkai Shi; 2013; 55(1):28-34. PubMed ID: 23461207 [No Abstract] [Full Text] [Related]
50. [Characteristics of the diabetic patients referred for the first time to the nephrologist]. Mora-Fernández C; Muros M; Jarque A; González-Cabrera F; García-Pérez J; Navarro J Nefrologia; 2007; 27(2):154-61. PubMed ID: 17564559 [TBL] [Abstract][Full Text] [Related]
51. [Clinical status of the patient at the time of dialysis onset. INESIR study]. Gómez-Campderá FJ; Orte L; Aguilar MD; Fernández Giráldez E; Lázaro P; Sanz Guajardo D; Nefrologia; 2006; 26 Suppl 3():12-8. PubMed ID: 17469422 [No Abstract] [Full Text] [Related]
52. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets. Lam A; Shah S; Paparello J Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654 [TBL] [Abstract][Full Text] [Related]
53. Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks. Campese VM; Park J J Hypertens; 2006 Nov; 24(11):2157-9. PubMed ID: 17053534 [No Abstract] [Full Text] [Related]
54. Chronic kidney disease: the ABC of nephrology. Yap HK Ann Acad Med Singap; 2007 Mar; 36(3):161-4. PubMed ID: 17450259 [No Abstract] [Full Text] [Related]
55. Anaemia is common and predicts mortality in diabetic nephropathy. Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197 [TBL] [Abstract][Full Text] [Related]
56. [Chronic kidney disease: do generalists and nephrologists differ in their care?]. Frimat L; Siewe G; Loos-Ayav C; Briançon S; Kessler M; Aubrège A Nephrol Ther; 2006 Jul; 2(3):127-35. PubMed ID: 16890137 [TBL] [Abstract][Full Text] [Related]
57. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984 [No Abstract] [Full Text] [Related]